Company / SG&A Expense
Cronos Group Inc. SG&A Expense History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$42.0M
FY2025
5-year range
$42.0M / $90.9M
FY2021-FY2025
Trend
-9.7%
vs FY2024
Sector context
#168 of 213
Health Care
What the data says
Cronos Group Inc.'s sg&a expense of $42M is lower than 79% of companies in the Health Care sector (FY2025). SG&A Expense has declined for 4 consecutive years, from $91M in FY2021 to $42M in FY2025.
Based on SEC 10-K filings.
$42M in FY2025 with a 5-year CAGR of +25.8%.
Improved from $49M to $42M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -19.5%
- 5-Year CAGR
- +25.8%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 213This company $42.0M Sector average $722.3M
▼
-94.2% below sector average
Key checks
Key Insights
- Cronos Group Inc.'s sg&a expense has declined for 4 consecutive years.
- 5-year CAGR of +25.8%, indicating consistent growth.
- In FY2025, sg&a expense decreased 9.7% year-over-year.
- Ranks #168 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.38 (safe zone, above 2.9 threshold)
- Strong profit margin: 34.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.0M | -9.7% |
| FY2024 | $46.5M | -6.0% |
| FY2023 | $49.5M | -38.6% |
| FY2022 | $80.6M | -11.4% |
| FY2021 | $90.9M | +581.1% |
| FY2020 | $13.3M | -83.6% |
| FY2019 | $81.5M | +510.4% |
| FY2018 | $13.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026